|
Market Closed -
Nasdaq
16:00:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 35.46 USD | +0.77% |
|
-0.67% | -15.57% |
| 09-25 | UBS Cuts Medline Price Target to $43 From $45, Maintains Buy Rating | MT |
| 09-15 | Medline Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 12:20 PM |
| Market Cap | 31.11B 27.69B 25.66B 23.26B 43.71B 2,947B 44.44B 308B 121B 1,542B 117B 114B 4,920B | P/E 2026 * |
47.6x | P/E 2027 * | 31.2x |
|---|---|---|---|---|---|
| Enterprise Value | 41B 36.49B 33.82B 30.65B 57.6B 3,884B 58.56B 406B 159B 2,033B 154B 151B 6,484B | EV / Sales 2026 * |
1.31x | EV / Sales 2027 * | 1.17x |
| Free-Float |
66.56% | Yield 2026 * |
0.2% | Yield 2027 * | 0.27% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MDLN | Delayed | |
CBOE
| MDLN | Real-time | |
|
BOERSE DUESSELDORF
| L10 | End-of-day quote | |
|
Deutsche Boerse AG
| L10 | Delayed | |
|
Tradegate
| L10 | Real-time | |
|
Boerse Muenchen
| L10 | Real-time | |
|
Xetra
| L10 | Delayed |
Last Transcript: Medline Inc.
| 1 day | +0.77% | ||
| 1 week | -0.84% | ||
| Current month | +2.19% | ||
| 1 month | +12.07% | ||
| 3 months | -10.88% | ||
| 6 months | -25.57% | ||
| Current year | -15.57% |
| 1 week | 35 |  | 37.02 |
| 1 month | 31.63 | | 37.02 |
| Current year | 31.49 | | 50.88 |
| 1 year | 31.49 | | 50.88 |
| 3 years | 31.49 | | 50.88 |
| 5 years | 31.49 | | 50.88 |
| 10 years | 31.49 | | 50.88 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | GIC Pte Ltd. (Investment Management)
| Sell | Company | -7,816,987 | 0.8910% | |
| 10/6/26 | GIC Pte Ltd. (Investment Management)
| Sell | Company | -9,272,000 | 1.0568% | |
| 8/19/26 | Free | Chief Operating Officer | 87,667 | 0.0119% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.77% | -0.84% | - | - | 30.87B | |
| -1.55% | +0.62% | -20.30% | +7.34% | 180B | |
| +2.00% | +2.94% | -1.20% | +30.79% | 114B | |
| +2.17% | +7.71% | -18.70% | +13.40% | 114B | |
| -1.02% | +2.56% | -51.84% | -7.18% | 78.39B | |
| +0.96% | +5.60% | +5.72% | +80.77% | 64.88B | |
| +1.60% | +3.73% | +17.39% | +76.86% | 54.02B | |
| +1.60% | +2.60% | +2.49% | -24.73% | 51.96B | |
| +0.38% | +6.49% | -12.19% | +31.07% | 43.79B | |
| -0.28% | -0.21% | +28.74% | -0.35% | 32.45B | |
| Average | +0.66% | +2.51% | -5.54% | +23.11% | 76.43B | |
| Weighted average by Cap. | +0.50% | +2.79% | -11.12% | +20.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 31.23B 27.8B 25.76B 23.35B 43.87B 2,959B 44.61B 309B 121B 1,548B 117B 115B 4,939B | 33.68B 29.98B 27.79B 25.18B 47.32B 3,191B 48.11B 333B 131B 1,670B 126B 124B 5,327B |
| Net income | 944M 840M 778M 705M 1.33B 89.39B 1.35B 9.34B 3.67B 46.78B 3.54B 3.47B 149B | 1.54B 1.37B 1.27B 1.15B 2.16B 146B 2.2B 15.24B 5.99B 76.35B 5.78B 5.66B 244B |
| Net Debt | 9.89B 8.8B 8.16B 7.39B 13.89B 937B 14.13B 97.89B 38.45B 490B 37.09B 36.32B 1,564B | 8.43B 7.5B 6.95B 6.3B 11.84B 798B 12.04B 83.43B 32.77B 418B 31.61B 30.96B 1,333B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | US$35.46 | +0.77% | 9,602,927 |
| 26-10-19 | US$35.19 | -2.14% | 7,697,366 |
| 26-10-16 | US$35.96 | -1.67% | 7,079,323 |
| 26-10-15 | US$36.57 | +1.78% | 7,660,181 |
| 26-10-14 | US$35.93 | +0.64% | 4,637,886 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDLN Stock
Select your edition
All financial news and data tailored to specific country editions
